Collectively, our study revealed that PSMB8 can not only be a useful prognostic factor in glioma patients, but also a predictive marker of prognostic factors and novel therapeutic target by blocking key proteins of TGF-β signaling. The gene discussed is PSMB8; the disease is glioma.